Cargando…
The challenges with the validation of research antibodies
This article further discusses the reproducibility crisis in biomedical science and how poor conduct of commercial antibodies contribute to this. In addition, the way quality data are presented on product sheets by antibody vendors is scrutinized. The article proposes that there is a distinction bet...
Autor principal: | Voskuil, Jan L.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333605/ https://www.ncbi.nlm.nih.gov/pubmed/28357047 http://dx.doi.org/10.12688/f1000research.10851.1 |
Ejemplares similares
-
Commercial antibodies and their validation
por: Voskuil, JLA
Publicado: (2014) -
How difficult is the validation of clinical biomarkers?
por: Voskuil, Jan
Publicado: (2015) -
Although it's painful: The importance of stringent antibody validation
por: Meliopoulos, Victoria A., et al.
Publicado: (2018) -
siRNA knockdown validation 101: Incorporating negative controls in antibody research
por: Olds, Will, et al.
Publicado: (2016) -
A global approach to addressing the policy, research and social challenges of male reproductive health
por: Barratt, Christopher L R, et al.
Publicado: (2021)